FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $20.12B

Holdings (237)

SPY SPDR S&P 500 ETF TR 4.4%
Value $886M Shares 2,235,000 Share Price $396.33 Est. Cost/Share — Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 4.4%
Value $883M Shares 5,775,000 Share Price $152.91 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 4.2%
Value $836M Shares 404,351 Share Price $2068.63 Est. Cost/Share — Unrealized @ Report Date —
IQV IQVIA HLDGS INC 3.9%
Value $786M Shares 4,069,181 Share Price $193.14 Est. Cost/Share — Unrealized @ Report Date —
WTW WILLIS TOWERS WATSON PLC LTD 3.6%
Value $715M Shares 3,124,200 Share Price $228.88 Est. Cost/Share — Unrealized @ Report Date —
AON AON PLC 2.8%
Value $565M Shares 2,454,194 Share Price $230.11 Est. Cost/Share — Unrealized @ Report Date —
TMO THERMO FISHER SCIENTIFIC INC 2.6%
Value $527M Shares 1,155,078 Share Price $456.38 Est. Cost/Share — Unrealized @ Report Date —
TMUS T-MOBILE US INC 2.6%
Value $515M Shares 4,108,826 Share Price $125.29 Est. Cost/Share — Unrealized @ Report Date —
BSX BOSTON SCIENTIFIC CORP 2.5%
Value $496M Shares 12,822,869 Share Price $38.65 Est. Cost/Share — Unrealized @ Report Date —
— XILINX INC 2.3%
Value $458M Shares 3,696,000 Share Price $123.90 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 2.2%
Value $452M Shares 1,916,248 Share Price $235.77 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 2.2%
Value $442M Shares 3,142,318 Share Price $140.61 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 2.0%
Value $412M Shares 1,399,205 Share Price $294.53 Est. Cost/Share — Unrealized @ Report Date —
ARMK ARAMARK 2.0%
Value $411M Shares 10,868,450 Share Price $37.78 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC 1.9%
Value $392M Shares 4,946,946 Share Price $79.16 Est. Cost/Share — Unrealized @ Report Date —
RTX RAYTHEON TECHNOLOGIES CORP 1.8%
Value $370M Shares 4,782,411 Share Price $77.27 Est. Cost/Share — Unrealized @ Report Date —
CNC CENTENE CORP DEL 1.8%
Value $359M Shares 5,625,000 Share Price $63.91 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 1.8%
Value $353M Shares 2,600,000 Share Price $135.61 Est. Cost/Share — Unrealized @ Report Date —
MA MASTERCARD INCORPORATED 1.7%
Value $351M Shares 985,920 Share Price $356.05 Est. Cost/Share — Unrealized @ Report Date —
BX BLACKSTONE GROUP INC 1.6%
Value $330M Shares 4,431,121 Share Price $74.53 Est. Cost/Share — Unrealized @ Report Date —
AVGO BROADCOM INC 1.6%
Value $316M Shares 682,247 Share Price $463.66 Est. Cost/Share — Unrealized @ Report Date —
— INPHI CORP 1.5%
Value $311M Shares 1,744,800 Share Price $178.41 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 1.5%
Value $302M Shares 1,426,875 Share Price $211.87 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 1.5%
Value $296M Shares 825,000 Share Price $358.95 Est. Cost/Share — Unrealized @ Report Date —
— SLACK TECHNOLOGIES INC 1.5%
Value $294M Shares 7,227,300 Share Price $40.63 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 1.4%
Value $292M Shares 395,141 Share Price $738.01 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 1.4%
Value $284M Shares 3,160,077 Share Price $90.00 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 1.4%
Value $280M Shares 454,178 Share Price $617.02 Est. Cost/Share — Unrealized @ Report Date —
— GW PHARMACEUTICALS PLC 1.4%
Value $277M Shares 1,278,900 Share Price $216.90 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 1.4%
Value $277M Shares 1,308,829 Share Price $211.73 Est. Cost/Share — Unrealized @ Report Date —
— MAXIM INTEGRATED PRODS INC 1.3%
Value $270M Shares 2,957,400 Share Price $91.37 Est. Cost/Share — Unrealized @ Report Date —
— AMYRIS INC 1.3%
Value $258M Shares 13,500,000 Share Price $19.10 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 1.2%
Value $243M Shares 10,750,000 Share Price $22.59 Est. Cost/Share — Unrealized @ Report Date —
HLT HILTON WORLDWIDE HLDGS INC 1.2%
Value $236M Shares 1,949,437 Share Price $120.92 Est. Cost/Share — Unrealized @ Report Date —
— BHP GROUP PLC 1.2%
Value $231M Shares 4,000,521 Share Price $57.86 Est. Cost/Share — Unrealized @ Report Date —
— NEW ORIENTAL ED & TECHNOLOGY 1.1%
Value $223M Shares 15,943,000 Share Price $14.00 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.8%
Value $157M Shares 1,900,000 Share Price $82.45 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 0.8%
Value $153M Shares 676,400 Share Price $226.73 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTRAPEUTICS INC 0.7%
Value $150M Shares 4,750,000 Share Price $31.66 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.7%
Value $146M Shares 850,000 Share Price $171.30 Est. Cost/Share — Unrealized @ Report Date —
— LUFAX HOLDING LTD 0.7%
Value $143M Shares 9,833,399 Share Price $14.52 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A/S 0.6%
Value $129M Shares 1,000,000 Share Price $128.88 Est. Cost/Share — Unrealized @ Report Date —
— QIAGEN NV 0.6%
Value $124M Shares 2,538,423 Share Price $48.69 Est. Cost/Share — Unrealized @ Report Date —
NYT NEW YORK TIMES CO 0.6%
Value $120M Shares 2,379,622 Share Price $50.62 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.5%
Value $110M Shares 606,629 Share Price $181.13 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 0.5%
Value $109M Shares 14,994,867 Share Price $7.30 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 0.5%
Value $98.83M Shares 700,000 Share Price $141.19 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.5%
Value $98.39M Shares 1,995,000 Share Price $49.32 Est. Cost/Share — Unrealized @ Report Date —
— MOMO INC 0.5%
Value $96.83M Shares 110,077,000 Share Price $0.88 Est. Cost/Share — Unrealized @ Report Date —
HWM HOWMET AEROSPACE INC 0.5%
Value $94.97M Shares 2,955,729 Share Price $32.13 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.5%
Value $93.33M Shares 2,175,000 Share Price $42.91 Est. Cost/Share — Unrealized @ Report Date —
— GENERATION BIO CO 0.5%
Value $93.08M Shares 3,270,500 Share Price $28.46 Est. Cost/Share — Unrealized @ Report Date —
PCG PG&E CORP 0.4%
Value $85.39M Shares 7,292,042 Share Price $11.71 Est. Cost/Share — Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 0.4%
Value $81.16M Shares 675,000 Share Price $120.23 Est. Cost/Share — Unrealized @ Report Date —
— CORELOGIC INC 0.4%
Value $77.27M Shares 975,000 Share Price $79.25 Est. Cost/Share — Unrealized @ Report Date —
BCAB BIOATLA INC 0.4%
Value $75.86M Shares 1,492,060 Share Price $50.84 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.4%
Value $75.72M Shares 81,762,000 Share Price $0.93 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.4%
Value $75M Shares 7,170,213 Share Price $10.46 Est. Cost/Share — Unrealized @ Report Date —
RVMD REVOLUTION MEDICINES INC 0.4%
Value $73.85M Shares 1,609,730 Share Price $45.88 Est. Cost/Share — Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 0.3%
Value $67.56M Shares 694,791 Share Price $97.23 Est. Cost/Share — Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.3%
Value $64.55M Shares 1,250,000 Share Price $51.64 Est. Cost/Share — Unrealized @ Report Date —
— KANSAS CITY SOUTHERN 0.3%
Value $63.34M Shares 240,000 Share Price $263.92 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.3%
Value $62.81M Shares 2,425,000 Share Price $25.90 Est. Cost/Share — Unrealized @ Report Date —
— ARENA PHARMACEUTICALS INC 0.3%
Value $58.98M Shares 850,000 Share Price $69.39 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.3%
Value $58.44M Shares 1,683,700 Share Price $34.71 Est. Cost/Share — Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.3%
Value $58.15M Shares 2,500,000 Share Price $23.26 Est. Cost/Share — Unrealized @ Report Date —
— THERAVANCE BIOPHARMA INC 0.3%
Value $57.93M Shares 56,695,000 Share Price $1.02 Est. Cost/Share — Unrealized @ Report Date —
— INSMED INC 0.3%
Value $56.62M Shares 50,000,000 Share Price $1.13 Est. Cost/Share — Unrealized @ Report Date —
— PRA HEALTH SCIENCES INC 0.3%
Value $53.67M Shares 350,000 Share Price $153.33 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.3%
Value $53.52M Shares 2,465,000 Share Price $21.71 Est. Cost/Share — Unrealized @ Report Date —
— APHRIA INC 0.3%
Value $50.81M Shares 2,765,800 Share Price $18.37 Est. Cost/Share — Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.2%
Value $48.15M Shares 625,000 Share Price $77.04 Est. Cost/Share — Unrealized @ Report Date —
LNTH LANTHEUS HLDGS INC 0.2%
Value $48.08M Shares 2,250,000 Share Price $21.37 Est. Cost/Share — Unrealized @ Report Date —
BEAM BEAM THERAPEUTICS INC 0.2%
Value $47.42M Shares 592,481 Share Price $80.04 Est. Cost/Share — Unrealized @ Report Date —
— TURNING POINT THERAPEUTICS I 0.2%
Value $47.3M Shares 500,000 Share Price $94.59 Est. Cost/Share — Unrealized @ Report Date —
ATTOF ATENTO S A 0.2%
Value $46.81M Shares 2,230,357 Share Price $20.99 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.2%
Value $43.96M Shares 2,107,400 Share Price $20.86 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.2%
Value $43.92M Shares 2,250,000 Share Price $19.52 Est. Cost/Share — Unrealized @ Report Date —
ANNX ANNEXON INC 0.2%
Value $40.53M Shares 1,455,846 Share Price $27.84 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.2%
Value $39.24M Shares 51,910,000 Share Price $0.76 Est. Cost/Share — Unrealized @ Report Date —
— IKENA ONCOLOGY INC 0.2%
Value $38.12M Shares 1,349,513 Share Price $28.25 Est. Cost/Share — Unrealized @ Report Date —
— REALPAGE INC 0.2%
Value $36.19M Shares 415,000 Share Price $87.20 Est. Cost/Share — Unrealized @ Report Date —
QTRX QUANTERIX CORP 0.2%
Value $35.08M Shares 600,000 Share Price $58.47 Est. Cost/Share — Unrealized @ Report Date —
— CHANGE HEALTHCARE INC 0.2%
Value $32.13M Shares 1,453,600 Share Price $22.10 Est. Cost/Share — Unrealized @ Report Date —
NVAX NOVAVAX INC 0.2%
Value $31.73M Shares 175,000 Share Price $181.31 Est. Cost/Share — Unrealized @ Report Date —
— COHERENT INC 0.2%
Value $31.61M Shares 125,000 Share Price $252.89 Est. Cost/Share — Unrealized @ Report Date —
PLRX PLIANT THERAPEUTICS INC 0.1%
Value $30.06M Shares 764,262 Share Price $39.33 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.1%
Value $29.64M Shares 29,689,000 Share Price $1.00 Est. Cost/Share — Unrealized @ Report Date —
BIIB BIOGEN INC 0.1%
Value $28.81M Shares 103,000 Share Price $279.75 Est. Cost/Share — Unrealized @ Report Date —
IONS IONIS PHARMACEUTICALS INC 0.1%
Value $28.35M Shares 630,500 Share Price $44.96 Est. Cost/Share — Unrealized @ Report Date —
— KHOSLA VENTURES ACQUT CO III 0.1%
Value $28.06M Shares 2,809,000 Share Price $9.99 Est. Cost/Share — Unrealized @ Report Date —
— VARIAN MED SYS INC 0.1%
Value $26.48M Shares 150,000 Share Price $176.53 Est. Cost/Share — Unrealized @ Report Date —
NUVB NUVATION BIO INC 0.1%
Value $26.13M Shares 2,500,000 Share Price $10.45 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.1%
Value $25.82M Shares 345,000 Share Price $74.85 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.1%
Value $25.54M Shares 25,000,000 Share Price $1.02 Est. Cost/Share — Unrealized @ Report Date —
— ISIS PHARMACEUTICALS INC DEL 0.1%
Value $24.8M Shares 24,435,000 Share Price $1.01 Est. Cost/Share — Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.1%
Value $24.1M Shares 500,000 Share Price $48.20 Est. Cost/Share — Unrealized @ Report Date —
— CLEVER LEAVES HOLDINGS INC 0.1%
Value $23.44M Shares 2,278,079 Share Price $10.29 Est. Cost/Share — Unrealized @ Report Date —
— CONSTELLATION PHARMCETICLS I 0.1%
Value $23.39M Shares 1,000,000 Share Price $23.39 Est. Cost/Share — Unrealized @ Report Date —
— ORCHARD THERAPEUTICS PLC 0.1%
Value $23.34M Shares 3,215,434 Share Price $7.26 Est. Cost/Share — Unrealized @ Report Date —
— KHOSLA VENTURES ACQUSTN CO I 0.1%
Value $22.7M Shares 2,250,000 Share Price $10.09 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.1%
Value $22.36M Shares 300,000 Share Price $74.53 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.1%
Value $20.68M Shares 20,000,000 Share Price $1.03 Est. Cost/Share — Unrealized @ Report Date —
— REVOLUTION HEALTHCAR AQ CORP 0.1%
Value $20.1M Shares 2,000,000 Share Price $10.05 Est. Cost/Share — Unrealized @ Report Date —
— DECARBONIZATION PLUS ACQU II 0.1%
Value $19.92M Shares 2,000,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.1%
Value $18.95M Shares 600,000 Share Price $31.58 Est. Cost/Share — Unrealized @ Report Date —
— FIVE PRIME THERAPEUTICS INC 0.1%
Value $18.9M Shares 501,618 Share Price $37.67 Est. Cost/Share — Unrealized @ Report Date —
— FORTRESS VALUE ACQUISI CORP 0.1%
Value $17.32M Shares 1,750,000 Share Price $9.90 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAPITAL CORP 0.1%
Value $16.78M Shares 1,250,226 Share Price $13.42 Est. Cost/Share — Unrealized @ Report Date —
— ACHILLES THERAPEUTICS PLC 0.1%
Value $16.55M Shares 1,000,000 Share Price $16.55 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A/S 0.1%
Value $16.3M Shares 510,000 Share Price $31.96 Est. Cost/Share — Unrealized @ Report Date —
— NOVAVAX INC 0.1%
Value $16.1M Shares 10,000,000 Share Price $1.61 Est. Cost/Share — Unrealized @ Report Date —
RCEL AVITA MEDICAL INC 0.1%
Value $15.86M Shares 800,000 Share Price $19.82 Est. Cost/Share — Unrealized @ Report Date —
BEKE KE HLDGS INC 0.1%
Value $15.56M Shares 273,000 Share Price $56.98 Est. Cost/Share — Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 0.1%
Value $15.53M Shares 350,000 Share Price $44.37 Est. Cost/Share — Unrealized @ Report Date —
— AUSTERLITZ ACQUISITION CORP 0.1%
Value $15.04M Shares 1,500,000 Share Price $10.03 Est. Cost/Share — Unrealized @ Report Date —
— KKR ACQUISITION HOLDING I CO 0.1%
Value $15.02M Shares 1,500,000 Share Price $10.01 Est. Cost/Share — Unrealized @ Report Date —
— ADVERUM BIOTECHNOLOGIES INC 0.1%
Value $14.79M Shares 1,500,000 Share Price $9.86 Est. Cost/Share — Unrealized @ Report Date —
— EXTENDED STAY AMER INC 0.1%
Value $14.13M Shares 715,499 Share Price $19.75 Est. Cost/Share — Unrealized @ Report Date —
— DISRUPTIVE ACQUISITION CORP 0.1%
Value $13.83M Shares 1,400,000 Share Price $9.88 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.1%
Value $13.45M Shares 300,000 Share Price $44.84 Est. Cost/Share — Unrealized @ Report Date —
— LONGBOARD PHARMACEUTICALS IN 0.1%
Value $13.28M Shares 810,500 Share Price $16.38 Est. Cost/Share — Unrealized @ Report Date —
— NUANCE COMMUNICATIONS INC 0.1%
Value $12.94M Shares 7,000,000 Share Price $1.85 Est. Cost/Share — Unrealized @ Report Date —
— CHIMERIX INC 0.1%
Value $12.53M Shares 1,300,000 Share Price $9.64 Est. Cost/Share — Unrealized @ Report Date —
— FOREST ROAD ACQUISITION COR 0.1%
Value $12.45M Shares 1,250,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.1%
Value $12.14M Shares 702,110 Share Price $17.29 Est. Cost/Share — Unrealized @ Report Date —
— INHIBRX INC 0.1%
Value $12.04M Shares 600,000 Share Price $20.07 Est. Cost/Share — Unrealized @ Report Date —
— AGILE GROWTH CORP 0.1%
Value $11.9M Shares 1,200,000 Share Price $9.92 Est. Cost/Share — Unrealized @ Report Date —
— DARIOHEALTH CORP 0.1%
Value $11.56M Shares 600,000 Share Price $19.26 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.1%
Value $11.44M Shares 172,454 Share Price $66.31 Est. Cost/Share — Unrealized @ Report Date —
— CURIS INC 0.1%
Value $11.32M Shares 1,000,000 Share Price $11.32 Est. Cost/Share — Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 0.1%
Value $11.31M Shares 400,000 Share Price $28.27 Est. Cost/Share — Unrealized @ Report Date —
— NGM BIOPHARMACEUTICALS INC 0.1%
Value $10.9M Shares 375,000 Share Price $29.07 Est. Cost/Share — Unrealized @ Report Date —
GRND TIGA ACQUISITION CORP 0.1%
Value $10.84M Shares 1,080,000 Share Price $10.04 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.1%
Value $10.16M Shares 200,000 Share Price $50.79 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $10.11M Shares 300,000 Share Price $33.69 Est. Cost/Share — Unrealized @ Report Date —
— PLURALSIGHT INC 0.0%
Value $10.05M Shares 450,000 Share Price $22.34 Est. Cost/Share — Unrealized @ Report Date —
— ROCKET INTERNET GRWT OPRT CO 0.0%
Value $10.01M Shares 1,000,000 Share Price $10.01 Est. Cost/Share — Unrealized @ Report Date —
— ARES ACQUISITION CORPORATION 0.0%
Value $10M Shares 1,000,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— CHURCHILL CAPITAL CORP VII 0.0%
Value $9.97M Shares 1,000,000 Share Price $9.97 Est. Cost/Share — Unrealized @ Report Date —
— FS DEVELOPMENT CORP II 0.0%
Value $9.96M Shares 1,000,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
— CORAZON CAPITAL V838 MONOCER 0.0%
Value $9.95M Shares 1,000,000 Share Price $9.95 Est. Cost/Share — Unrealized @ Report Date —
— VIRGIN GROUP ACQUISIT CORP I 0.0%
Value $9.93M Shares 1,000,000 Share Price $9.93 Est. Cost/Share — Unrealized @ Report Date —
— FORUM MERGER IV CORP 0.0%
Value $9.9M Shares 1,000,000 Share Price $9.90 Est. Cost/Share — Unrealized @ Report Date —
— TAILWIND TWO ACQUISITION COR 0.0%
Value $9.88M Shares 1,000,000 Share Price $9.88 Est. Cost/Share — Unrealized @ Report Date —
— CASCADE ACQUISITION CORP 0.0%
Value $9.702M Shares 990,000 Share Price $9.80 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.0%
Value $9.391M Shares 740,000 Share Price $12.69 Est. Cost/Share — Unrealized @ Report Date —
— GOSSAMER BIO INC 0.0%
Value $8.889M Shares 10,000,000 Share Price $0.89 Est. Cost/Share — Unrealized @ Report Date —
— ALBIREO PHARMA INC 0.0%
Value $8.813M Shares 250,000 Share Price $35.25 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.0%
Value $8.582M Shares 4,125,877 Share Price $2.08 Est. Cost/Share — Unrealized @ Report Date —
— ARYA SCIENCES ACQU CORP IV 0.0%
Value $8.32M Shares 800,000 Share Price $10.40 Est. Cost/Share — Unrealized @ Report Date —
— BOLT BIOTRAPEUTICS INC 0.0%
Value $8.228M Shares 250,000 Share Price $32.91 Est. Cost/Share — Unrealized @ Report Date —
JWSUF JAWS MUSTANG ACQUISITION COR 0.0%
Value $8.12M Shares 800,000 Share Price $10.15 Est. Cost/Share — Unrealized @ Report Date —
— LEVERE HOLDINGS CORP 0.0%
Value $7.968M Shares 800,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
— SURFACE ONCOLOGY INC 0.0%
Value $7.8M Shares 1,000,000 Share Price $7.80 Est. Cost/Share — Unrealized @ Report Date —
— KINNATE BIOPHARMA INC 0.0%
Value $7.79M Shares 250,000 Share Price $31.16 Est. Cost/Share — Unrealized @ Report Date —
— RESEARCH ALLIANCE CORP II 0.0%
Value $7.688M Shares 750,000 Share Price $10.25 Est. Cost/Share — Unrealized @ Report Date —
— GORES METROPOULOS II INC 0.0%
Value $7.59M Shares 750,000 Share Price $10.12 Est. Cost/Share — Unrealized @ Report Date —
— WARBURG PINCUS CAPTAL CORP I 0.0%
Value $7.56M Shares 750,000 Share Price $10.08 Est. Cost/Share — Unrealized @ Report Date —
— REINVENT TECHNOLOGY PARTNERS 0.0%
Value $7.53M Shares 750,000 Share Price $10.04 Est. Cost/Share — Unrealized @ Report Date —
— ARCLIGHT CLEAN TRANSITION II 0.0%
Value $7.5M Shares 750,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— WARBURG PINCUS CAPTAL CORP I 0.0%
Value $7.485M Shares 750,000 Share Price $9.98 Est. Cost/Share — Unrealized @ Report Date —
— APOLLO STRATEGIC GRWT CPTL I 0.0%
Value $7.485M Shares 750,000 Share Price $9.98 Est. Cost/Share — Unrealized @ Report Date —
— GORES HOLDINGS VII INC 0.0%
Value $7.47M Shares 750,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
— SOCIAL LEVERAGE ACQUISN CORP 0.0%
Value $7.463M Shares 750,000 Share Price $9.95 Est. Cost/Share — Unrealized @ Report Date —
— VECTOR ACQUISITION CORP II 0.0%
Value $7.425M Shares 750,000 Share Price $9.90 Est. Cost/Share — Unrealized @ Report Date —
— PATHFINDER ACQUISITION CORP 0.0%
Value $7.425M Shares 750,000 Share Price $9.90 Est. Cost/Share — Unrealized @ Report Date —
— THUNDER BRIDGE CAP PRTNRS II 0.0%
Value $7.418M Shares 750,000 Share Price $9.89 Est. Cost/Share — Unrealized @ Report Date —
— CONNECT BIOPHARMA HLDGS LTD 0.0%
Value $7.4M Shares 400,000 Share Price $18.50 Est. Cost/Share — Unrealized @ Report Date —
— NOVUS CAPITAL CORPORATION II 0.0%
Value $7M Shares 700,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— SUPERNOVA PARTN ACQ CO III L 0.0%
Value $7M Shares 700,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $6.435M Shares 6,783,000 Share Price $0.95 Est. Cost/Share — Unrealized @ Report Date —
— FINCH THERAPEUTICS GROUP INC 0.0%
Value $6.205M Shares 390,000 Share Price $15.91 Est. Cost/Share — Unrealized @ Report Date —
— IMMUNOGEN INC 0.0%
Value $6.075M Shares 750,000 Share Price $8.10 Est. Cost/Share — Unrealized @ Report Date —
— KHOSLA VENTURES ACQUISITION 0.0%
Value $6.06M Shares 600,000 Share Price $10.10 Est. Cost/Share — Unrealized @ Report Date —
— GORES TECHNOLOGY PARTNERS II 0.0%
Value $5.982M Shares 600,000 Share Price $9.97 Est. Cost/Share — Unrealized @ Report Date —
— FINSERV ACQUISITION CORP II 0.0%
Value $5.979M Shares 600,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
— INTERPRIVATE IV INFRATECH PR 0.0%
Value $5.934M Shares 600,000 Share Price $9.89 Est. Cost/Share — Unrealized @ Report Date —
— RXR ACQUISITION CORP 0.0%
Value $5.91M Shares 600,000 Share Price $9.85 Est. Cost/Share — Unrealized @ Report Date —
PHVS PHARVARIS N V 0.0%
Value $5.612M Shares 200,000 Share Price $28.06 Est. Cost/Share — Unrealized @ Report Date —
COGT UNUM THERAPEUTICS INC 0.0%
Value $5.268M Shares 600,000 Share Price $8.78 Est. Cost/Share — Unrealized @ Report Date —
— HARPOON THERAPEUTICS INC 0.0%
Value $5.23M Shares 250,000 Share Price $20.92 Est. Cost/Share — Unrealized @ Report Date —
TBA THOMA BRAVO ADVANTAGE 0.0%
Value $5.225M Shares 500,000 Share Price $10.45 Est. Cost/Share — Unrealized @ Report Date —
CGEM CULLINAN ONCOLOGY INC 0.0%
Value $5.209M Shares 125,000 Share Price $41.67 Est. Cost/Share — Unrealized @ Report Date —
INNV INNOVAGE HLDG CORP 0.0%
Value $5.158M Shares 200,000 Share Price $25.79 Est. Cost/Share — Unrealized @ Report Date —
— SOARING EAGLE ACQUISITION CO 0.0%
Value $5.06M Shares 500,000 Share Price $10.12 Est. Cost/Share — Unrealized @ Report Date —
— AUSTERLITZ ACQUISITION CORP 0.0%
Value $5.02M Shares 500,000 Share Price $10.04 Est. Cost/Share — Unrealized @ Report Date —
— G SQUARED ASCEND I INC 0.0%
Value $5M Shares 500,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— FIFTH WALL ACQUISITION CORP 0.0%
Value $5M Shares 500,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— FTAC HERA ACQUISITION CORP 0.0%
Value $4.995M Shares 500,000 Share Price $9.99 Est. Cost/Share — Unrealized @ Report Date —
— LANDCADIA HOLDINGS IV INC 0.0%
Value $4.95M Shares 500,000 Share Price $9.90 Est. Cost/Share — Unrealized @ Report Date —
— COLONNADE ACQUISITION CORP I 0.0%
Value $4.925M Shares 500,000 Share Price $9.85 Est. Cost/Share — Unrealized @ Report Date —
— APELLIS PHARMACEUTICALS INC 0.0%
Value $4.886M Shares 3,522,000 Share Price $1.39 Est. Cost/Share — Unrealized @ Report Date —
EQ EQUILLIUM INC 0.0%
Value $4.862M Shares 680,000 Share Price $7.15 Est. Cost/Share — Unrealized @ Report Date —
— SCION TECH GROWTH II 0.0%
Value $4.482M Shares 450,000 Share Price $9.96 Est. Cost/Share — Unrealized @ Report Date —
— NIGHTDRAGON ACQUISITION CORP 0.0%
Value $4.08M Shares 400,000 Share Price $10.20 Est. Cost/Share — Unrealized @ Report Date —
— HUMANCO ACQUISITION CORP 0.0%
Value $4.069M Shares 408,900 Share Price $9.95 Est. Cost/Share — Unrealized @ Report Date —
— CHURCHILL CAPITAL CORP VI 0.0%
Value $4.024M Shares 400,000 Share Price $10.06 Est. Cost/Share — Unrealized @ Report Date —
— FIRST RESERVE SUSTAINABLE GW 0.0%
Value $4.014M Shares 400,000 Share Price $10.04 Est. Cost/Share — Unrealized @ Report Date —
— GORES HLDGS VIII INC 0.0%
Value $4M Shares 400,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— INTERPRIVATE II ACQUISITION 0.0%
Value $3.956M Shares 400,000 Share Price $9.89 Est. Cost/Share — Unrealized @ Report Date —
— AFFIMED N V 0.0%
Value $3.955M Shares 500,000 Share Price $7.91 Est. Cost/Share — Unrealized @ Report Date —
— ALKURI GLOBAL ACQUISITION CO 0.0%
Value $3.952M Shares 400,000 Share Price $9.88 Est. Cost/Share — Unrealized @ Report Date —
— VPC IMPACT ACQU HOLDI III IN 0.0%
Value $3.948M Shares 400,000 Share Price $9.87 Est. Cost/Share — Unrealized @ Report Date —
— INTERPRIVATE III FINANCIAL P 0.0%
Value $3.944M Shares 400,000 Share Price $9.86 Est. Cost/Share — Unrealized @ Report Date —
— CM LIFE SCIENCES II INC 0.0%
Value $3.2M Shares 250,000 Share Price $12.80 Est. Cost/Share — Unrealized @ Report Date —
— LONGVIEW ACQUISITION CORP II 0.0%
Value $3.059M Shares 304,698 Share Price $10.04 Est. Cost/Share — Unrealized @ Report Date —
— LAZARD GROWTH ACQUISITION CO 0.0%
Value $3M Shares 300,000 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
— SIGNIFY HEALTH INC 0.0%
Value $2.926M Shares 100,000 Share Price $29.26 Est. Cost/Share — Unrealized @ Report Date —
— NORTHERN GENESIS ACQUISITION 0.0%
Value $2.758M Shares 278,026 Share Price $9.92 Est. Cost/Share — Unrealized @ Report Date —
— SVF INVESTMENT CORP 0.0%
Value $2.553M Shares 250,000 Share Price $10.21 Est. Cost/Share — Unrealized @ Report Date —
— DRAGONEER GROWTH OPT CORP II 0.0%
Value $2.528M Shares 250,000 Share Price $10.11 Est. Cost/Share — Unrealized @ Report Date —
ACRS ACLARIS THERAPEUTICS INC 0.0%
Value $2.52M Shares 100,000 Share Price $25.20 Est. Cost/Share — Unrealized @ Report Date —
— GORES TECHNOLOGY PARTNERS IN 0.0%
Value $2.508M Shares 250,000 Share Price $10.03 Est. Cost/Share — Unrealized @ Report Date —
— LIVE OAK MOBILITY ACQUISI CO 0.0%
Value $2.495M Shares 250,000 Share Price $9.98 Est. Cost/Share — Unrealized @ Report Date —
— HUDSON EXECUTIVE INVES III 0.0%
Value $2.48M Shares 250,000 Share Price $9.92 Est. Cost/Share — Unrealized @ Report Date —
— SUPERNOVA PARTNERS ACQUISTN 0.0%
Value $2.008M Shares 200,000 Share Price $10.04 Est. Cost/Share — Unrealized @ Report Date —
— ARCTOS NORTHSTAR ACQUIS CORP 0.0%
Value $1.998M Shares 200,000 Share Price $9.99 Est. Cost/Share — Unrealized @ Report Date —
— VPC IMPACT ACQUISITION HLDG 0.0%
Value $1.972M Shares 200,000 Share Price $9.86 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.0%
Value $1.636M Shares 7,174,613 Share Price $0.23 Est. Cost/Share — Unrealized @ Report Date —
— LDH GROWTH CORP I 0.0%
Value $1.518M Shares 150,000 Share Price $10.12 Est. Cost/Share — Unrealized @ Report Date —
— PRIVETERRA ACQUISITION CORP 0.0%
Value $1.491M Shares 150,000 Share Price $9.94 Est. Cost/Share — Unrealized @ Report Date —
— THE MUSIC ACQUISITION CORP 0.0%
Value $1.248M Shares 125,000 Share Price $9.98 Est. Cost/Share — Unrealized @ Report Date —
— NORTHERN STAR INVEST CORP II 0.0%
Value $995K Shares 100,000 Share Price $9.95 Est. Cost/Share — Unrealized @ Report Date —
— NORTHERN STAR INVEST CORP IV 0.0%
Value $992K Shares 100,000 Share Price $9.92 Est. Cost/Share — Unrealized @ Report Date —
— CF ACQUISITION CORP VI 0.0%
Value $990K Shares 100,000 Share Price $9.90 Est. Cost/Share — Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 0.0%
Value $988K Shares 100,000 Share Price $9.88 Est. Cost/Share — Unrealized @ Report Date —
— ALPHA CAPITAL ACQUISITION CO 0.0%
Value $792K Shares 79,598 Share Price $9.95 Est. Cost/Share — Unrealized @ Report Date —
— TIGA ACQUISITION CORP 0.0%
Value $702K Shares 540,000 Share Price $1.30 Est. Cost/Share — Unrealized @ Report Date —
SLMUF SLAM CORP 0.0%
Value $699K Shares 70,508 Share Price $9.91 Est. Cost/Share — Unrealized @ Report Date —
— GOL LINHAS AEREAS INTELIGENT 0.0%
Value $657K Shares 85,838 Share Price $7.65 Est. Cost/Share — Unrealized @ Report Date —
— SPARTAN ACQUISITION CORP III 0.0%
Value $602K Shares 60,053 Share Price $10.02 Est. Cost/Share — Unrealized @ Report Date —
— CEREVEL THERAPEUTICS HLDNG I 0.0%
Value $566K Shares 134,175 Share Price $4.22 Est. Cost/Share — Unrealized @ Report Date —
— CASCADE ACQUISITION CORP 0.0%
Value $446K Shares 495,000 Share Price $0.90 Est. Cost/Share — Unrealized @ Report Date —
— HUMANCO ACQUISITION CORP 0.0%
Value $264K Shares 200,000 Share Price $1.32 Est. Cost/Share — Unrealized @ Report Date —
— NORTHERN GENESIS ACQUISITION 0.0%
Value $107K Shares 92,675 Share Price $1.15 Est. Cost/Share — Unrealized @ Report Date —
— SVF INVESTMENT CORP 0.0%
Value $104K Shares 50,000 Share Price $2.08 Est. Cost/Share — Unrealized @ Report Date —